IMVT
Immunovant Inc
NASDAQ · Biotechnology
$27.05
+2.99 (+12.43%)
Performance
1D
—
1W
+3.72%
1M
+4.80%
3M
+18.17%
6M
+70.23%
1Y
+38.58%
YTD
+4.40%
Open$26.88
Previous Close$24.06
Day High$27.35
Day Low$24.85
52W High$27.80
52W Low$12.72
Volume3.31M
Avg Volume1.52M
Market Cap5.45B
P/E Ratio—
EPS$-2.83
SectorBiotechnology
Volume Analysis
2.19x average volume
Technical Indicators
SMA 50
$25.48
Above
SMA 200
$19.15
Above
RSI (14)
54.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
23 analysts
Price Target
+125.3% upside
Current
$27.05
$27.05
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |